Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on Dec 08, 2021 10:20am
118 Views
Post# 34210281

RE:What might this mean, if anything, to TH?

RE:What might this mean, if anything, to TH? I do recall in the papers on sortilin, they also said higher levels were associated with dementia/alzheimers, this CAD, and as few other diseases.  As to how much is "higher" and how that compares to what a solid tumor creates, I don't know.

They may end up finding there's certain baseline characteristics that lower the efficacy or have side effects more. It seems a lot of these cancer drugs have pretty specific lanes they need to stay in for them to be used and see efficacy. This is where playing with that dosage --being able to use lower amounts more frequently or something like that --could come in handy for certain types of patients.

SPCEO1 wrote:
https://medicaldialogues.in/cardiology-ctvs/news/higher-circulating-sortilin-levels-linked-to-coronary-artery-disease-reveals-study-85496


<< Previous
Bullboard Posts
Next >>